{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:03:53Z","timestamp":1784541833356,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-55560-3","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:14:47Z","timestamp":1780042487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Downregulation of CXCL16\/ADAM10 axis by Simvastatin attenuates tacrolimus-induced tubulointerstitial fibrosis"],"prefix":"10.1038","volume":"16","author":[{"given":"Abdulrahman A.","family":"Alelowi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alulu","family":"Alradhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad H.","family":"Alhowail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha A.","family":"Aldubayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Abdel-Bakky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"55560_CR1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00668.x","author":"A Khanna","year":"2002","unstructured":"Khanna, A., Plummer, M., Bromberek, C., Bresnahan, B. & Hariharan, S. Expression of TGF-\u03b2 and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity. Kidney Int. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00668.x (2002).","journal-title":"Kidney Int."},{"key":"55560_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200108000-00006","author":"M Ahmed","year":"2001","unstructured":"Ahmed, M. et al. Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-\u03b3 inhibition in CD8- and CD8+ peripheral blood T cells. Ther. Drug Monit. https:\/\/doi.org\/10.1097\/00007691-200108000-00006 (2001).","journal-title":"Ther. Drug Monit."},{"key":"55560_CR3","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010080793","author":"M Zeisberg","year":"2010","unstructured":"Zeisberg, M. & Neilson, E. G. Mechanisms of tubulointerstitial fibrosis. J. Soc. Nephrol. https:\/\/doi.org\/10.1681\/ASN.2010080793 (2010).","journal-title":"J. Soc. Nephrol."},{"key":"55560_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120150","author":"T Shigematsu","year":"2022","unstructured":"Shigematsu, T. et al. The mTOR inhibitor everolimus attenuates tacrolimus-induced renal interstitial fibrosis in rats. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2021.120150 (2022).","journal-title":"Life Sci."},{"key":"55560_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2021.01.020","author":"R Fu","year":"2021","unstructured":"Fu, R. et al. Establishment of an experimental rat model of tacrolimus-induced kidney injury accompanied by interstitial fibrosis. Toxicol. Lett. https:\/\/doi.org\/10.1016\/j.toxlet.2021.01.020 (2021).","journal-title":"Toxicol. Lett."},{"key":"55560_CR6","doi-asserted-by":"crossref","unstructured":"Ren, Y. et al. Effects of tacrolimus on the TGF-\u03b21\/SMAD signaling pathway in paraquat-exposed rat alveolar type II epithelial cells. Mol. Med. Rep. 22, (2020).","DOI":"10.3892\/mmr.2020.11453"},{"key":"55560_CR7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.2000.01577.x","author":"GR Bicknell","year":"2000","unstructured":"Bicknell, G. R. et al. Differential effects of cyclosporin and tacrolimus on the expression of fibrosis-associated genes in isolated glomeruli from renal transplants. Br. J. Surg. https:\/\/doi.org\/10.1046\/j.1365-2168.2000.01577.x (2000).","journal-title":"Br. J. Surg."},{"key":"55560_CR8","doi-asserted-by":"crossref","unstructured":"Radhakrishnan, H., Stark, S. M. & Stark, C. E. L. Microstructural Alterations in Hippocampal Subfields Mediate Age-Related Memory Decline in Humans. Front. Aging Neurosci. 12, (2020).","DOI":"10.3389\/fnagi.2020.00094"},{"key":"55560_CR9","doi-asserted-by":"crossref","unstructured":"Xu, M., Xu, S. & Yi, X. A comparative analysis of drug-induced kidney injury adverse reactions between cyclosporine and tacrolimus based on the FAERS database. BMC Immunol. 26, (2025).","DOI":"10.1186\/s12865-025-00714-7"},{"key":"55560_CR10","doi-asserted-by":"publisher","first-page":"F433","DOI":"10.1152\/ajprenal.00226.2022","volume":"324","author":"AC Ume","year":"2023","unstructured":"Ume, A. C. et al. Tacrolimus induces fibroblast-to-myofibroblast transition via a TGFb-dependent mechanism to contribute to renal fibrosis. Am. J. Physiol. Renal Physiol. 324, F433\u2013F445 (2023).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"55560_CR11","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1248\/bpb.b23-00737","volume":"47","author":"ME Nady","year":"2024","unstructured":"Nady, M. E. & E.-R. E.-S. M. E.-S., O. M. A. Linagliptin mitigates TGF-\u03b21 mediated epithelial\u2013mesenchymal transition in tacrolimus-induced renal interstitial fibrosis via Smad\/ ERK\/P38 and HIF-1\u03b1\/LOXL2 signaling pathways. Biol. Pharm. Bull. 47, 1008\u20131020 (2024).","journal-title":"Biol. Pharm. Bull."},{"key":"55560_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfac237","author":"N Knops","year":"2023","unstructured":"Knops, N. et al. Tacrolimus induces a pro-fibrotic response in donor-derived human proximal tubule cells dependent on common variants of the CYP3A5 and ABCB1 genes. Nephrol. Dial. Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfac237 (2023).","journal-title":"Nephrol. Dial. Transplant."},{"key":"55560_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3897\/pharmacia.71.e137797","volume":"71","author":"MS Abdel-Bakky","year":"2024","unstructured":"Abdel-Bakky, M. S., Mohammed, H. A. & Amin, E. Inhibition of selective factor Xa suppresses Type 1 diabetes development in mice via the CXCL16 chemokine. Pharmacia 71, 1\u201310 (2024).","journal-title":"Pharmacia"},{"key":"55560_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120224","author":"MS Abdel-Bakky","year":"2022","unstructured":"Abdel-Bakky, M. S., Alqasoumi, A., Altowayan, W. M., Amin, E. & Darwish, M. A. Simvastatin mitigates streptozotocin-induced type 1 diabetes in mice through downregulation of ADAM10 and ADAM17. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2021.120224 (2022).","journal-title":"Life Sci."},{"key":"55560_CR15","doi-asserted-by":"publisher","DOI":"10.1160\/TH07-01-0035","author":"A Ludwig","year":"2007","unstructured":"Ludwig, A. & Weber, C. Transmembrane chemokines: Versatile \u2018special agents\u2019 in vascular inflammation. Thromb. Haemost. https:\/\/doi.org\/10.1160\/TH07-01-0035 (2007).","journal-title":"Thromb. Haemost."},{"key":"55560_CR16","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.060065","author":"GE Garcia","year":"2007","unstructured":"Garcia, G. E. et al. Inhibition of CXCL16 attenuates inflammatory and progressive phases of anti-glomerular basement membrane antibody-associated glomerulonephritis. Am. J. Pathol. https:\/\/doi.org\/10.2353\/ajpath.2007.060065 (2007).","journal-title":"Am. J. Pathol."},{"key":"55560_CR17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.10.7166","author":"T Wu","year":"2007","unstructured":"Wu, T. et al. Elevated urinary VCAM-1, P-Selectin, Soluble TNF Receptor-1, and CXC Chemokine Ligand 16 in multiple murine Lupus strains and human Lupus Nephritis. J. Immunol. https:\/\/doi.org\/10.4049\/jimmunol.179.10.7166 (2007).","journal-title":"J. Immunol."},{"key":"55560_CR18","doi-asserted-by":"crossref","unstructured":"Wu, F., Sun, C. & Lu, J. The Role of Chemokine Receptors in Renal Fibrosis. Rev.Physiol., Biochem. Pharmacol. 177 (2020).","DOI":"10.1007\/112_2020_21"},{"key":"55560_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2018.00153","author":"T Kato","year":"2018","unstructured":"Kato, T., Hagiyama, M. & Ito, A. Renal ADAM10 and 17: Their physiological and medical meanings. Front. Cell Develop. Biol. https:\/\/doi.org\/10.3389\/fcell.2018.00153 (2018).","journal-title":"Front. Cell Develop. Biol."},{"key":"55560_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-023-03492-6","author":"CA German","year":"2023","unstructured":"German, C. A. & Liao, J. K. Understanding the molecular mechanisms of statin pleiotropic effects. Arch. Toxicol. https:\/\/doi.org\/10.1007\/s00204-023-03492-6 (2023).","journal-title":"Arch. Toxicol."},{"key":"55560_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-024-03014-9","author":"C Bo","year":"2024","unstructured":"Bo, C. et al. Simvastatin attenuates silica-induced pulmonary inflammation and fibrosis in rats via the AMPK-NOX pathway. BMC Pulm. Med. https:\/\/doi.org\/10.1186\/s12890-024-03014-9 (2024).","journal-title":"BMC Pulm. Med."},{"key":"55560_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-14606-8","author":"MM Goki","year":"2025","unstructured":"Goki, M. M. et al. Low dose naloxone mitigates opioid tolerance and dependence and restores mesenchymal stem cell function for cell therapy in addiction. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-025-14606-8 (2025).","journal-title":"Sci. Rep."},{"key":"55560_CR23","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1111251","author":"J Schirmeister","year":"1964","unstructured":"Schirmeister, J., Willmann, H. & Kiefer, H. Plasmakreatinin als grober Indikator der Nierenfunktion. Dtsch. Med. Wochenschr. https:\/\/doi.org\/10.1055\/s-0028-1111251 (1964).","journal-title":"Dtsch. Med. Wochenschr."},{"key":"55560_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7922892","author":"S Suhariningsih","year":"2022","unstructured":"Suhariningsih, S. et al. Ameliorative and renoprotective effect of electrical stimulation on blood sugar, blood urea nitrogen (BUN), creatinine levels, and the islets of Langerhans weight in diabetic mice. Vet. Med. Int. https:\/\/doi.org\/10.1155\/2022\/7922892 (2022).","journal-title":"Vet. Med. Int."},{"key":"55560_CR25","doi-asserted-by":"publisher","unstructured":"Suvarna, S. K., Layton, C. & Bancroft, J. D. Bancroft\u2019s Theory and Practice of Histological Techniques, Eighth Edition. Bancroft\u2019s Theory and Practice of Histological Techniques, Eighth Edition (2018). https:\/\/doi.org\/10.1016\/C2015-0-00143-5.","DOI":"10.1016\/C2015-0-00143-5"},{"key":"55560_CR26","first-page":"135","volume":"15","author":"MS Abdel-Bakky","year":"2025","unstructured":"Abdel-Bakky, M. S. & Alharbi, N. B. Factor Xa inhibition mitigates tacrolimus-induced tubulointerstitial fibrosis via the PI3K\/p-AKT pathway. J. Appl. Pharm. Sci. 15, 135\u2013143 (2025).","journal-title":"J. Appl. Pharm. Sci."},{"key":"55560_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2005.02.011","author":"SH Akbas","year":"2005","unstructured":"Akbas, S. H. et al. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods. Clin. Biochem. https:\/\/doi.org\/10.1016\/j.clinbiochem.2005.02.011 (2005).","journal-title":"Clin. Biochem."},{"key":"55560_CR28","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.E0213","author":"A Nosari","year":"2004","unstructured":"Nosari, A. et al. Bone marrow hypoplasia complicating tacrolimus (FK506) therapy. Int. J. Hematol. https:\/\/doi.org\/10.1532\/IJH97.E0213 (2004).","journal-title":"Int. J. Hematol."},{"key":"55560_CR29","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04800908","author":"M Naesens","year":"2009","unstructured":"Naesens, M., Kuypers, D. R. J. & Sarwal, M. Calcineurin inhibitor nephrotoxicity. Clin. J. Am. Soc. Nephrol. https:\/\/doi.org\/10.2215\/CJN.04800908 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"55560_CR30","doi-asserted-by":"publisher","DOI":"10.1159\/000351648","author":"N Issa","year":"2013","unstructured":"Issa, N., Kukla, A. & Ibrahim, H. N. Calcineurin inhibitor nephrotoxicity: A review and perspective of the evidence. Am. J. Nephrol. https:\/\/doi.org\/10.1159\/000351648 (2013).","journal-title":"Am. J. Nephrol."},{"key":"55560_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000235527.81917.fe","author":"AO Ojo","year":"2006","unstructured":"Ojo, A. O. Cardiovascular complications after renal transplantation and their prevention. Transplantation https:\/\/doi.org\/10.1097\/01.tp.0000235527.81917.fe (2006).","journal-title":"Transplantation"},{"key":"55560_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2011.01625.x","author":"K Anastaze Stelle","year":"2012","unstructured":"Anastaze Stelle, K. et al. Glomerular and tubular function following orthotopic liver transplantation in children treated with tacrolimus. Pediatr. Transplant. https:\/\/doi.org\/10.1111\/j.1399-3046.2011.01625.x (2012).","journal-title":"Pediatr. Transplant."},{"key":"55560_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-9209-y","author":"Y Gonzalez-Lama","year":"2006","unstructured":"Gonzalez-Lama, Y., Gisbert, J. P. & Mate, J. The role of tacrolimus in inflammatory bowel disease: a systematic review. Digest. Diseas. Sci. https:\/\/doi.org\/10.1007\/s10620-006-9209-y (2006).","journal-title":"Digest. Diseas. Sci."},{"key":"55560_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2016.48","author":"XM Meng","year":"2016","unstructured":"Meng, X. M., Nikolic-Paterson, D. J. & Lan, H. Y. TGF-\u03b2: The master regulator of fibrosis. Nature Rev. Nephrol. https:\/\/doi.org\/10.1038\/nrneph.2016.48 (2016).","journal-title":"Nature Rev. Nephrol."},{"key":"55560_CR35","doi-asserted-by":"publisher","DOI":"10.1556\/2060.104.2017.2.8","author":"E \u00d6zk\u00f6k","year":"2017","unstructured":"\u00d6zk\u00f6k, E. et al. The impact of pretreatment with simvastatin on kidney tissue of rats with acute sepsis. Physiol. Int. https:\/\/doi.org\/10.1556\/2060.104.2017.2.8 (2017).","journal-title":"Physiol. Int."},{"key":"55560_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(01)00438-5","author":"N Ichimaru","year":"2001","unstructured":"Ichimaru, N. Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus. Atherosclerosis https:\/\/doi.org\/10.1016\/S0021-9150(01)00438-5 (2001).","journal-title":"Atherosclerosis"},{"key":"55560_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0323749","author":"S Sabeel","year":"2025","unstructured":"Sabeel, S. et al. Impact of statins as immune-modulatory agents on inflammatory markers in adults with chronic diseases: A systematic review and meta-analysis. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0323749 (2025).","journal-title":"PLoS ONE"},{"key":"55560_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-024-01514-6","author":"J Pu","year":"2024","unstructured":"Pu, J. et al. Simvastatin reduces chronic kidney disease and renal failure risk in type 2 diabetes patients: Post hoc ACCORD trial analysis. Diabetol. Metab. Syndr. https:\/\/doi.org\/10.1186\/s13098-024-01514-6 (2024).","journal-title":"Diabetol. Metab. Syndr."},{"key":"55560_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000054","author":"Y Liu","year":"2006","unstructured":"Liu, Y. Renal fibrosis: New insights into the pathogenesis and therapeutics. Kidney Int. https:\/\/doi.org\/10.1038\/sj.ki.5000054 (2006).","journal-title":"Kidney Int."},{"key":"55560_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214434","author":"J Yu","year":"2022","unstructured":"Yu, J., Sharma, P., Girgis, C. M. & Gunton, J. E. Vitamin D and beta cells in type 1 diabetes: A systematic review. Int. J. Mole. Sci. https:\/\/doi.org\/10.3390\/ijms232214434 (2022).","journal-title":"Int. J. Mole. Sci."},{"key":"55560_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2024.01.004","author":"A Mehta","year":"2024","unstructured":"Mehta, A. Managing dyslipidemia in solid organ transplant patients. Indian Heart J. https:\/\/doi.org\/10.1016\/j.ihj.2024.01.004 (2024).","journal-title":"Indian Heart J."},{"key":"55560_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)91513-6","author":"JF Moorhead","year":"1982","unstructured":"Moorhead, J. F., El-Nahas, M., Chan, M. K. & Varghese, Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet https:\/\/doi.org\/10.1016\/S0140-6736(82)91513-6 (1982).","journal-title":"Lancet"},{"key":"55560_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-025-01290-2","author":"P Theofilis","year":"2025","unstructured":"Theofilis, P., Vlachakis, P. K., Karakasis, P. & Kalaitzidis, R. G. Managing Dyslipidemia in Chronic Kidney Disease: Implications for Cardiovascular and Renal Risk. Curr. Atheroscler. Rep. https:\/\/doi.org\/10.1007\/s11883-025-01290-2 (2025).","journal-title":"Curr. Atheroscler. Rep."},{"key":"55560_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073490","author":"J Korbecki","year":"2021","unstructured":"Korbecki, J. et al. The role of cxcl16 in the pathogenesis of cancer and other diseases. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22073490 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"55560_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh859","author":"JM Vieira","year":"2005","unstructured":"Vieira, J. M. et al. Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. Nephrol. Dial. Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfh859 (2005).","journal-title":"Nephrol. Dial. Transplant."},{"key":"55560_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2012.71","author":"Y Hamasaki","year":"2012","unstructured":"Hamasaki, Y. et al. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor simvastatin ameliorates renal fibrosis through HOXA13-USAG-1 pathway. Lab. Invest. https:\/\/doi.org\/10.1038\/labinvest.2012.71 (2012).","journal-title":"Lab. Invest."},{"key":"55560_CR47","doi-asserted-by":"crossref","unstructured":"Koka, S. et al. Podocyte NLRP3 inflammasome activation and formation by adipokine visfatin. Cell. Physiol. Biochem. 53, (2019).","DOI":"10.33594\/000000143"},{"key":"55560_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118110","author":"S Datta","year":"2025","unstructured":"Datta, S., Rahman, M. A., Koka, S. & Boini, K. M. Mitigation of nicotine-induced podocyte injury through inhibition of thioredoxin interacting protein. Biomed. Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2025.118110 (2025).","journal-title":"Biomed. Pharmacother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55560-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55560-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55560-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:20:13Z","timestamp":1784539213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55560-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55560"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55560-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were approved by the Qassim University Ethical Committee (Approval No: 25-11-20) and followed NIH and ARRIVE 2.0 guidelines.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22662"}}